0 CHECKOUT

Cataract - Pipeline Review, H1 2015

  • ID: 3280643
  • May 2015
  • 50 pages
  • Global Markets Direct
1 of 4

Cataract - Pipeline Review, H1 2015

Summary

This, ‘Cataract - Pipeline Review, H1 2015’, provides an overview of the Cataract’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Cataract, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cataract and special features on late-stage and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all READ MORE >

Note: Product cover images may vary from those shown
2 of 4

List of Tables
List of Figures
Introduction
REPORT COVERAGE
Cataract Overview
Therapeutics Development
Pipeline Products for Cataract - Overview
Pipeline Products for Cataract - Comparative Analysis
Cataract - Therapeutics under Development by Companies
Cataract - Therapeutics under Investigation by Universities/Institutes
Cataract - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Cataract - Products under Development by Companies
Cataract - Products under Investigation by Universities/Institutes
Cataract - Companies Involved in Therapeutics Development
CalAsia Pharmaceuticals, Inc.
EyeGate Pharmaceuticals, Inc.
InSite Vision Incorporated
Laboratorios Sophia S.A. de C.V.
Laila Pharmaceuticals Pvt. Ltd.
Omeros Corporation
R-Tech Ueno, Ltd.
Cataract - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
(bromfenac sodium + dexamethasone acetate) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
(sulfasalazine + Hyaluronic Acid) - Drug Profile
Product Description
Mechanism of Action
R&D Progress
dexamethasone acetate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
LP-01309 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PRO-155 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
RTU-007 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Antagonize GPR161 for Metastatic Epithelial Cancers, Congenital Cataracts and Birth Defects of the Brain and Spinal Cord - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit NFkB for Ophthalmology, Oncology and Immunology - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Non-Surgical Cataracts and Multiple Sclerosis - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Ophthalmology and CNS Disorders - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Ophthalmology, Cardiovascular, CNS and Metabolic Disorders - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cataract - Recent Pipeline Updates
Cataract - Dormant Projects
Cataract - Discontinued Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Cataract, H1 2015
Number of Products under Development for Cataract - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Investigation by Universities/Institutes, H1 2015
Cataract - Pipeline by CalAsia Pharmaceuticals, Inc., H1 2015
Cataract - Pipeline by EyeGate Pharmaceuticals, Inc., H1 2015
Cataract - Pipeline by InSite Vision Incorporated, H1 2015
Cataract - Pipeline by Laboratorios Sophia S.A. de C.V., H1 2015
Cataract - Pipeline by Laila Pharmaceuticals Pvt. Ltd., H1 2015
Cataract - Pipeline by Omeros Corporation, H1 2015
Cataract - Pipeline by R-Tech Ueno, Ltd., H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Cataract Therapeutics - Recent Pipeline Updates, H1 2015
Cataract - Dormant Projects, H1 2015
Cataract - Discontinued Products, H1 2015

List of Figures
Number of Products under Development for Cataract, H1 2015
Number of Products under Development for Cataract - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Note: Product cover images may vary from those shown
3 of 4

- CalAsia Pharmaceuticals, Inc.
- EyeGate Pharmaceuticals, Inc.
- InSite Vision Incorporated
- Laboratorios Sophia S.A. de C.V.
- Laila Pharmaceuticals Pvt. Ltd.
- Omeros Corporation
- R-Tech Ueno, Ltd.

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Alcon Incorporated
  • Bausch & Lomb, Inc.
  • Essilor International S.A.
  • Johnson & Johnson Services, Inc.
  • Specsavers Optical Group Ltd.
  • Luxottica Group